Latest Impairment News

Noumi Limited reported modest revenue growth and a significant rise in adjusted EBITDA for FY25, driven by its Milklab brand’s strong performance and a continued turnaround in its Dairy & Nutritionals segment. The company also resolved all legacy legal issues, positioning itself for future growth.

Noumi Limited has posted a significant $150 million loss for the year ending June 2025, driven by non-cash charges and raising questions about its financial stability.

Acusensus Limited reported a robust FY25 with 20% revenue growth and a significant 84% jump in total contract value, setting the stage for an ambitious FY26 forecast of up to 41% revenue increase.

Acusensus Limited reported a 20% increase in revenue to $59.35 million for FY25, driven by new and expanded contracts across Australia, New Zealand, the US, and the UK. However, net losses widened by 72.3%, reflecting higher operating expenses and ongoing litigation costs.

K&S Corporation reported a 9% decline in underlying profit before tax for FY2025, alongside a 9.7% drop in revenue, as it invests heavily in property and terminal upgrades while navigating safety regulatory pressures.

Kogan.com Ltd reported robust FY25 growth driven by its core platform, despite setbacks from Mighty Ape's platform migration. The company declared a solid dividend and outlined a cautious but optimistic FY26 outlook.

Kogan.com Ltd reported robust FY25 results with strong sales growth, margin improvement, and a rapidly expanding customer base, while navigating challenges at Mighty Ape. The company outlined ambitious plans to boost profitability through platform-based sales and product margin optimisation.

Kogan.com Ltd reported robust FY25 growth with a 35% increase in active customers and a 20.5% rise in platform sales revenue, offset by a significant goodwill impairment at subsidiary Mighty Ape. The group declared a 7.0 cent final dividend and announced key board changes.

Santos Limited reports a 31% drop in net profit for H1 2025 despite increased sales volumes and progress on key projects, while receiving a non-binding acquisition proposal from an Abu Dhabi-led consortium.

Close the Loop Limited reported a 7% decline in revenue to $195.1 million for FY25, alongside a significant net loss increase to $21.9 million, driven by operational challenges and one-off costs. The company is navigating leadership changes and portfolio adjustments while maintaining a focus on sustainability and circular economy growth.

Genetic Signatures reported a 63% revenue increase to $15.9 million in FY25, alongside a 28% reduction in underlying losses and a strategic shift in its automated diagnostics platform development.

Genetic Signatures Limited reported a 63% revenue surge to $15.9 million in FY25, driven by strong Australian sales and progress in EMEA, while navigating a $20.1 million net loss and a strategic pivot towards partnerships for automated diagnostics.